Nyxoah SA Ordinary Shares (no par value) Controlled Equity OfferingSM Sales AgreementSales Agreement • December 22nd, 2022 • Nyxoah SA • Surgical & medical instruments & apparatus • New York
Nyxoah SA, a limited liability company (naamloze vennootschap/société anonyme) organized under the laws of Belgium (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
● ] Shares[1] Nyxoah SA Ordinary Shares PURCHASE AGREEMENTPurchase Agreement • June 25th, 2021 • Nyxoah SA • Surgical & medical instruments & apparatus • New York
Nyxoah SA, a limited liability company (naamloze vennootschap/société anonyme) organized under the laws of Belgium (the “Company”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [ ● ] Ordinary Shares (the “Firm Shares”), with no nominal value (the “Ordinary Shares”), of the Company. The Company has also granted to the several Underwriters an option to purchase up to [ ● ] additional Ordinary Shares on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement (this “Agreement”) are herein collectively called the “Securities.”
5,374,755 Shares1 Nyxoah SA Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • May 24th, 2024 • Nyxoah SA • Surgical & medical instruments & apparatus • New York
Nyxoah SA, a limited liability company (naamloze vennootschap/société anonyme) organized under the laws of Belgium (the “Company”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 5,374,755 Ordinary Shares (the “Firm Shares”), with no nominal value (the “Ordinary Shares”), of the Company. The Company has also granted to the Representative an option to purchase up to 806,213 additional Ordinary Shares on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement (this “Agreement”) are herein collectively called the “Securities.”
Unprotected Lease Contract Made and signed in Tel Aviv on August 20, 2020.Lease Contract • June 10th, 2021 • Nyxoah SA • Surgical & medical instruments & apparatus
Whereas the Landlord is the holder (owner of the property) and the owner of the exclusive rights of ownership in the Building, as defined in this agreement, which includes the Leased Premises, as defined in this agreement; and
CONFIDENTIAL TREATMENT REQUESTED - REDACTED COPY MULTIPARTY AGREEMENT AMONG [***], NYXOAH, CEPHALIX, GLUCOBEL, SURGICAL ELECTRONICS, MAN & SCIENCEMultiparty Agreement • June 10th, 2021 • Nyxoah SA • Surgical & medical instruments & apparatus • New York
In this agreement (the “Agreement”) Dr. [***] (“[***]”), an individual residing at [***], Nyxoah SA (“Nyxoah”), a corporation of Belgium whose post office address is 2 Rue Fond Cattelain, B-1435 Mont-St-Guibert, Belgium, company number 0817.149.675; Man & Science SA (“Man & Science”), a corporation of Belgium whose post office address is 2 Rue Fond Cattelain, B-1435 Mont-St-Guibert, Belgium, company number 0837.403.572; Cephalix SA (“Cephalix”), a corporation of Belgium whose post office address is 2 Rue Fond Cattelain, B-1435 Mont-St-Guibert, Belgium, company number 0837.403.770 ; Glucobel SA (“Glucobel”), a corporation of Belgium whose post office address is 2 Rue Fond Cattelain, B-1435 Mont-St-Guibert, Belgium, company number 0840.135.410; and Surgical Electronics SA (“Surgical Electronics”), a corporation of Belgium whose post office address is 2 Rue Fond Cattelain, B-1435 Mont-St-Guibert, Belgium, company number 0837.403.671 (collectively, the “Parties”), agree as follows:
Between: Gush 7093 Parcel 162 Ltd. Tax ID 510583156 126 Yigal Alon Street, Tel Aviv Hereinafter: “the Lessor” on the one side And: Nyxoah Ltd. Tax ID 514082726 126 Yigal Alon Street, Tel Aviv Hereinafter: “the Lessee” on the other sideRental Agreement • March 20th, 2024 • Nyxoah SA • Surgical & medical instruments & apparatus
Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep TestDistribution Agreement • August 2nd, 2022 • Nyxoah SA • Surgical & medical instruments & apparatus
Mont-Saint-Guibert, Belgium – August 2, 2022, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company has entered into a distribution agreement with Acurable SL, a venture-backed medical device company developing wearable technologies for home use, to provide the AcuPebble SA100 home sleep test to OSA patients in Germany.
Attachment to Rental Agreement Drafted and signed in Tel Aviv on November 30, 2023Rental Agreement • March 20th, 2024 • Nyxoah SA • Surgical & medical instruments & apparatus
Between: Gush 7093 Parcel 162 Ltd. Tax ID 510583156 126 Yigal Alon Street, Tel Aviv Hereinafter: “the Lessor” on the one side And: Nyxoah Ltd. Tax ID 514082726 126 Yigal Alon Street, Tel Aviv Hereinafter: “the Lessee” on the other side
